Hanseníase tuberculóide apresentando-se como lesão "em raquete de tênis" : relato de um caso típico

Adrielle P. S. Carneiro; Milton Cury Filho; Mariana da Mota S. Correia; Elaine V. C. Marcos; Fabiana C. Souza; Maria E. S. Nogueira; Jaison A. Barreto

doi:10.47878/hi.2008.v33.36243

Authors

Adrielle P. S. Carneiro Médica Residente em Dermatologia, Instituto Lauro de Souza Lima.
Milton Cury Filho Médico, Ortopedista, Instituto Lauro de Souza Lima.
Mariana da Mota S. Correia Médica Residente em Dermatologia, Instituto Lauro de Souza Lima.
Elaine V. C. Marcos Pesquisadora Científica, Instituto Lauro de Souza Lima.
Fabiana C. Souza Pesquisadora Científica, Instituto Lauro de Souza Lima.
Maria E. S. Nogueira Pesquisadora Científica, Instituto Lauro de Souza Lima.
Jaison A. Barreto Médico, Dermatologista, Coordenador do Programa de Residência. Médica em Dermatologia do Instituto Lauro de Souza Lima.

DOI:

https://doi.org/10.47878/hi.2008.v33.36243

Abstract

Tuberculoid leprosy is characterized, usually, by single or few lesions which show intense and localized neural impairement. The “racket lesion”, which is described as pathognomonic of tuberculoid leprosy, presents with a cutaneous nerve branch emerging from a tuberculoid plaque. It is reported a case of a 61 years old male, with diagnosis of tuberculoid leprosy, whose lesion remained active even after the end of PB multidrugtherapy (PB-MDT). At dermatologic examination, enlargement of the sensitive cutaneous branch of the ulnar nerve was observed, which emerged from a tuberculoid plaque on the dorsum of the right hand, characterizing a “racket lesion”. Serology for anti-PGL-1 was negative, and the Mitsuda reaction was highly positive, confir-ming the diagnosis of tuberculoid leprosy. MDT-PB was reinitiated, with little improvement. In this report, we describe the typical evolution of leprosy in individuals with positive Mitsuda reaction, where the MDT does not change the natural history of the disease.

Downloads

Download data is not yet available.

References

1 Opromolla DVA, ed. Noções de Hansenologia. 1 Bauru: Centro de Estudos “Dr. Reynaldo Quagliato”; 2000.
2 Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev 2006; 19 (2): 338-81.
3 Roitt I, Brostoff J, Male D. Imunidade às bactérias e aos fungos. In: Imunologia 5 ed. São Paulo: Manole; 1999. p.229-42.
4 Abbas AK, Lichtman AH. The major histocompatibility complex. In: Cellular and Molecular Immunology. USA: Saunders; 2003. p. 65-80.
5 Khanolkar-Young S, Snowdon D, Lockwood DNJ. Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-beta (TFG-β) in leprosy lesions. Clin Exp Immunol 1998; (113):438-42.
6 Opromolla DVA. Ação terapêutica das drogas anti-hansênicas e evidências de persistência microbiana nos casos paucibacilares. Hansen Int. 2004; 29 (1): 1-3.
7 Lima LS, Alayon FL. Sobre a significação patológica das lesões incaracterísticas (maculares simples). Revistas dos Tribunais 1941.
8 Visentainer JEL, Tsuneto LT, Serra MF, Peixoto PRF, Petzl-Erler ML. Association of leprosy with HLA DR-2 in a southern brazilian population. Braz J Med Rev 1997; (30): 51-9.
9 Marcos EVC, Souza FC, Ura S, Opromolla DVA. Estudo de associação entre antígenos HLA e reação hansênica tipo 1 ulcerada. Anais Bras Dermatologia 2000; 75 (3):283-90.
10 Mira MT. Genetic host resistance and susceptibility to leprosy. Microbes Infect 2006; (8):1124-31.
11 Dharmendra. Classification of leprosy. In: Hastings RC. Leprosy, 2nd ed. New York: Churchill Livingstone; 1994. p.179-90.
12 Azulay RD. Lepromin retesting as a factor of lepromin test positivation. Int J Lepr 1974; (42): 428.
13 Bechelli LM. The influence of repeated lepromin testing on the Mitsuda reaction in healthy people. Int J Lepr 1959; (27):228.